Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pisani, A.
Right arrow Articles by Iadecola, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pisani, A.
Right arrow Articles by Iadecola, C.

(Stroke. 1998;29:196-202.)
© 1998 American Heart Association, Inc.


Original Contributions

L-Type Ca2+ Channel Blockers Attenuate Electrical Changes and Ca2+ Rise Induced by Oxygen/Glucose Deprivation in Cortical Neurons

Antonio Pisani, MD; Paolo Calabresi, MD; Alessandro Tozzi; Vincenza D'Angelo; Giorgio Bernardi, MD

From the Clinica Neurologica (A.P., P.C., A.T., V.D.), Dipartimento di Sanità, Università "Tor Vergata," and Ospedale S. Lucia, IRCCS, Rome, Italy.

Correspondence to Antonio Pisani, MD, Clinica Neurologica, Dipartimento di Sanità, Università "Tor Vergata," Via di Tor Vergata 135, 00133 Rome, Italy. E-mail pisani{at}utovrm.it


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMaterials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
down arrowIntroduction 
down arrowReferences 
 
Background and Purpose—Experimental evidence supports a major role of increased intracellular calcium [Ca2+]i levels in the induction of neuronal damage during cerebral ischemia. However, the source of Ca2+ rise has not been fully elucidated. To clarify further the role and the origin of Ca2+ in cerebral ischemia, we have studied the effects of various pharmacological agents in an in vitro model of oxygen (O2)/glucose deprivation.

Methods—Pyramidal cortical neurons were intracellularly recorded from a slice preparation. Electrophysiological recordings and microfluorometric measurements of [Ca2+]i were performed simultaneously in slices perfused with a glucose-free physiological medium equilibrated with a 95% N2/5% CO2 gas mixture.

Results—Eight to twelve minutes of O2/glucose deprivation induced an initial membrane hyperpolarization, followed by a delayed, large but reversible membrane depolarization. The depolarization phase was accompanied by a transient increase in [Ca2+]i levels. When O2/glucose deprivation exceeded 13 to 15 minutes, both membrane depolarization and [Ca2+]i rise became irreversible. The dihydropyridines nifedipine and nimodipine significantly reduced either the membrane depolarization or the [Ca2+]i elevation. In contrast, tetrodotoxin had no effect on either of these parameters. Likewise, antagonists of ionotropic and group I and II metabotropic glutamate receptors failed to reduce the depolarization of the cell membrane and the [Ca2+]i accumulation. Finally, dantrolene, blocker of intracellular Ca2+ release, did not reduce both electrical and [Ca2+]i changes caused by O2/glucose depletion.

Conclusions—This work supports a role of L-type Ca2+ channels both in the electrical and ionic changes occurring during the early phases of O2/glucose deprivation.


Key Words: calcium channels • electrophysiology • fura 2 • glucose • ischemia • oxygen


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMaterials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
down arrowIntroduction 
down arrowReferences 
 
Ischemic stroke remains a common cause of severe neurological disability. In the recent past, an intensive effort has been directed at clarifying the pathophysiological mechanisms underlying neuronal degeneration during ischemic injury. Several studies have shown that the acute changes in neuronal electrical properties induced by either anoxia, aglycemia, or a combination of both, are extremely variable, depending on the brain area analyzed.1 For example, nigral dopaminergic and CA1 and CA3 hippocampal neurons hyperpolarize in response to anoxia,2 3 whereas brain stem and striatal neurons depolarize.4 5 During anoxia, cortical neurons exhibit an early hyperpolarization followed by a delayed membrane depolarization.6 7 The differential responses observed during energy deprivation are thought to underlie the diverse vulnerability of neuronal subtypes to energy metabolism failure.1 Compelling evidence led to the hypothesis that calcium [Ca2+]i overload is involved in neuronal injury occurring in cerebral hypoxia or ischemia.8 9 10 Mechanisms responsible for the elevation of [Ca2+]i during ischemia include opening of transmitter- or voltage-gated channels, mobilization from intracellular pools, inhibition of ion pumps, imbalance of sodium/Ca2+ exchanger.11 However, despite these advances in the understanding of the ischemia-related events, the origin of Ca2+ influx has not been defined precisely.

Cortical neurons are among the most vulnerable cell subtypes in the brain if exposed to energy deprivation.8 This susceptibility is believed to derive from a high metabolic demand and poor energy storage capability.12 Electrophysiological studies performed on rat and human neocortical slices demonstrated that neocortical cells maintain membrane potential for relatively long periods of oxygen or glucose deprivation alone.6 7 However, when these neurons were deprived of both oxygen and glucose, membrane potential changes were much faster, suggesting that anaerobic glycolysis has a crucial importance in the maintenance of ionic gradients across the cell membrane in these cells.6 By means of a combined approach of electrophysiological recordings and microfluorometric measurements of Ca2+ concentrations, we have recently shown that in cortical neurons the time-course of the anoxia-induced membrane potential changes closely resembles the data by Jiang and Haddad.6 Additionally, we have reported that [Ca2+]i elevations occur simultaneously with electrical changes.7

Therefore, in an attempt to analyze further the source of [Ca2+]i increase during O2/glucose deprivation, we examined simultaneously both the electrophysiological alterations and the [Ca2+]i changes, with the Ca2+-sensitive dye fura 2, in a cortical slice preparation. We then tested the efficacy of various pharmacological agents in counteracting these changes and found that membrane depolarization triggers an increase in [Ca2+]i, which is mainly dependent on the opening of voltage-gated L-type Ca2+ channels.


*    Materials and Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Materials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
down arrowIntroduction 
down arrowReferences 
 
Seventy-two male Wistar rats (age, postnatal day 18 to 24) were used for the experiments. Preparation and maintenance of the slices have been described5 7 13 previously and followed the institutional guidelines. Briefly, animals were killed under ether anesthesia by cervical dislocation, the brain was removed, and coronal slices (200-µm thick), containing cortex and striatum, were cut with a vibratome. Slices were maintained at 34°C in an oxygenated solution (see composition below) for about 1 hour. A single slice was then transferred to a recording chamber and fully submerged in a continuously flowing Krebs solution (33°C, 3 ml/min) gassed with 95% O2/5% CO2. The composition of the solution was (in millimoles per liter): 126 NaCl, 2.5 KCl, 1.2 MgCl2, 1.2 NaH2PO4, 2.4 CaCl2, 11 glucose, 25 NaHCO3. The ischemic medium was a glucose-free solution equilibrated with a 95% N2/5% CO2 gas mixture. Glucose was replaced with saccharose to balance osmolarity. Complete replacement of the medium in the chamber took 60 to 90 seconds. Only one single experiment was performed on each slice.

For simultaneous optical and electrical recordings, the tip of the recording electrode was filled with a solution of 2 mmol/L fura 2 (pentapotassium salt, Molecular Probes, The Netherlands), biocytin (2 to 4%, Sigma), and 100 mmol/L KCl, while the shank was backfilled with a 2 mol/L KCl solution. After cell impalement, cells were loaded with both fura 2 and biocytin by injecting, through the recording electrode, 0.1 to 0.5 nA negative current for 10 to 15 minutes. This loading procedure interfered neither with electrical nor with optical recordings. After the experiment, each biocytin-stained slice was fixed in paraformaldehyde (in 0.1 mmol/L phosphate buffer at pH 7.4) overnight and then processed according to standardized protocols.14 Sections were processed further to make permanent staining of biocytin-loaded cells, according to Kawaguchi.15

An Axoclamp 2A amplifier (Axon Instruments) was used for electrophysiology. Traces were displayed on an oscilloscope and stored on a digital system. The recording chamber was mounted on the stage of an upright microscope (Axioskop FS, Zeiss), equipped with a 60x water immersion objective (Olympus). Epi-illumination was provided by a 75-W Xenon lamp. Excitation light passed through a shutter and was filtered at 340 and 380 nm. Emission light was filtered by a long-pass barrier filter (500 to 530 nm) and detected by a CCD camera (Photonic Science, UK). Images were stored and analyzed off-line (IonVision, ImproVision, UK). The background fluorescence was measured in a part of the slice with no fura 2–filled neurons and subtracted from the signal to obtain the basal fluorescence level (F). Changes in [Ca2+]i are expressed in terms of {Delta}F/F, where {Delta}F is the normalized change in fluorescence and F is the background-subtracted basal fluorescence. The {Delta}F/F value can be interpreted as changes in [Ca2+]i.16 17 Changes in mitochondrial NADH levels during energy deprivation are known to interfere with fura 2 signals.18 Therefore, some undyed slices were exposed to O2/glucose deprivation, and the resulting raw fluorescence was detected, averaged, and subtracted from the control signal obtained in dyed slices. In most of the experiments, the intensity of excitation light was small; thus the fluorescence signals resulting from photo-bleaching of the dye were negligible. Values in the text and in the table are expressed as mean±SEM. Student's t test was used to compare the means. The experiments performed to check the possible effect of the pharmacological agents (nimodipine, D-APV, CNQX, MCPG, BAY K 8644, and dantrolene) on both the membrane potential changes and the elevation of the [Ca2+]i of the recorded cells, were first statistically analyzed using an ANOVA test. The result from this test has indicated a large and significant difference between groups (P<.001) so that we proceeded with the Student's t test to compare the means of each group referred, one by one, to the control.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
*Results
down arrowDiscussion
down arrowReferences
down arrowIntroduction 
down arrowReferences 
 
Electrophysiological and Morphological Features of Cortical Cells
Data were obtained from electrophysiologically and visually identified cortical pyramidal neurons. Pyramidal cortical neurons showed a resting membrane potential of -73±6 mV. As previously described,19 20 during depolarizing current pulses, two types of pyramidal cells were observed: "regular-spiking" and "bursting" neurons. In both of these types of pyramidal neurons, spikes were followed by a pronounced afterhyperpolarization. As described above (see Materials and Methods section) electrodes were filled with both fura 2 and biocytin. This loading procedure allowed an immediate visualization of the recorded cell (Fig 1ADown), due to fluorescence emission of the Ca2+-sensitive dye fura 2. In addition, subsequent processing of the loaded slices permitted morphological analysis. Pyramidal (IV layer) cells had a large soma (28 to 33 µm) and an extensive dendritic tree densely studded with spines (Fig 1BDown and 1CDown).



View larger version (72K):
[in this window]
[in a new window]
 
Figure 1. Morphological identification of cortical pyramidal neurons. A, The figure represents a computerized reconstruction of images (average of 256 frames) of a fura 2–loaded pyramidal cell. White arrow indicates the recording electrode. B, Biocytin-staining of the same cell in A. C, Permanent staining of the same neuron in A and B. Note the large size of the soma, the prominent apical dendrite, and the dendritic tree studded with spines. Scale bars=25 µm (A), 12 mm (B), 11 mm (C).

Effects of O2/Glucose Deprivation on Cortical Pyramidal Neurons
Perfusion with an ischemic solution for short periods induced small membrane potential changes in cortical neurons. In fact, 2 to 6 minutes of O2/glucose deprivation caused either no change or a small, not significant hyperpolarization of the recorded neurons (-5±3 mV, P>.01, n=118). Likewise, these changes in membrane potential were not coupled with significantly relevant [Ca2+]i changes (98±0.7 expressed as percentage of control, in terms of {Delta}F/F, see Materials and Methods section; P>.01, n=118). Longer periods of omission of O2 and glucose (8 to 12 min) caused an early membrane hyperpolarization followed by a delayed, large depolarization of the cell membrane (48±12 mV, P<.005, n=96). This membrane depolarization was associated with a transient, delayed increase in [Ca2+]i (54±9%, P<.001). Fig 2Down shows that an 8-minute perfusion with a solution lacking both O2 and glucose, produced a late, significant increase in [Ca2+]i (Fig 2ADown), which was fully reversible on washout. Simultaneously, a delayed, large membrane depolarization occurred (Fig 2BDown), followed, after the washout, by a pronounced afterhyperpolarization. When O2/glucose depletion exceeded 13 to 15 minutes, both the electrical changes and the increase in [Ca2+]i were irreversible (n=18, not shown).



View larger version (30K):
[in this window]
[in a new window]
 
Figure 2. O2/glucose deprivation-induced membrane depolarization and increase in [Ca2+]i in a cortical neuron. A, Eight minutes of energy depletion caused a delayed, reversible increase [Ca2+]i as indicated by changes in normalized fura 2 fluorescence intensity ({Delta}F/F). B, Concurrently, O2/glucose deprivation induced an initial membrane hyperpolarization of the recorded cell followed by a large depolarization. Note the pronounced afterhyperpolarization after the end of the exposure to O2/glucose depletion. In both A and B the horizontal bar represents the period of exposure to O2/glucose deprivation. C, Pseudocolor ratio images of Ca2+ signals expressing changes in {Delta}F/F at times shown in A. Color bar codes for {Delta}F/F. Resting membrane potential was -77 mV.

Role of L-Type Ca2+ Channels in In Vitro Ischemia
To address the possible involvement of L-type voltage-dependent Ca2+ channels in the early events that follow the onset of O2/glucose deprivation, we tested the effects of nifedipine, a dihydropyridine-derivative, on the electrical and [Ca2+]i changes caused in this experimental condition. The incubation with nifedipine (10 to 15 min), before starting perfusion with the O2/glucose-deprived medium, did not affect the intrinsic membrane properties of the recorded cells (resting membrane potential, input resistance, action potential discharge, not shown). Fig 3Down shows that in the presence of a saturating concentration of nifedipine (20 µmol/L), both the [Ca2+]i rise and the membrane depolarization caused by 10 minutes of O2/glucose deprivation (Fig 3ADown), were significantly reduced (Fig 3BDown, 17±3% of control, P<.001 and 21.7±1.7%, P<.003, respectively, n=18). After washout of the drug, the membrane response and [Ca2+]i rise induced by O2/glucose depletion returned to the control values (Fig 3CDown). Both the changes in membrane potential and [Ca2+]i were reduced by nifedipine in a dose-dependent manner (Fig 4Down). The EC50 value for the effect on membrane potential changes was 1.826 µmol/L, whereas the EC50 for the inhibition of [Ca2+]i increase was 3.288 µmol/L.



View larger version (9K):
[in this window]
[in a new window]
 
Figure 3. Effects of nifedipine on membrane depolarization and [Ca2+]i increase caused by O2/glucose depletion. A, In control condition, perfusion with a O2/glucose-deprived solution (10 minutes) caused a late, but significant, rise in [Ca2+]i expressed in terms of normalized fluorescence signal (upper graph). Simultaneously, an early hyperpolarization occurred, followed by a large, transient depolarization of the cell membrane (lower graph). B, In the presence of a saturating dose of nifedipine (20 µmol/L), the Ca2+ signal observed during exposure to O2/glucose deprivation was significantly smaller (upper graph). Likewise, in the presence of nifedipine (20 µmol/L), the amplitude of the membrane depolarization of the recorded cell was reduced (lower graph). C, After a 20-minute washout of nifedipine, a full recovery both of Ca2+ signal and membrane depolarization was observed (upper and lower graph, respectively). Horizontal bar indicates the period of exposure to O2/glucose deprivation (10 minutes). Resting membrane potential was -74 mV.



View larger version (14K):
[in this window]
[in a new window]
 
Figure 4. Dose-response curve of the effects of nifedipine on both membrane potential and [Ca2+]i during exposure to O2/glucose depletion. Each point represents the average of at least four single experiments (± SEM). Normalized data points were fitted according to the formula y = m3 (m0m1/(m0m1 + m2m1)), where m2 defines the EC50 values: the EC50 value for the effect on membrane potential changes ({Delta}Vm) was 1.826 µmol/L, whereas the EC50 for the inhibition of [Ca2+]i increase ({Delta}F/F) was 3.288 µmol/L.

In addition, we tested the action of nimodipine on this in vitro model of ischemia. A maximal concentration of nimodipine (20 µmol/L) significantly reduced both the [Ca2+]i elevation (Fig 5Down, 18±2% of control, P<.003, n=7), and the concurrent depolarization of the cell membrane (Fig 5Down, 22±3.1%, P<.001). Finally, we tested the effect of BAY K 8644 (3 µmol/L), an agonist of L-type Ca2+ channels. BAY K 8644, per se, produced significant changes neither in the passive properties of the recorded cells, nor in the resting [Ca2+]i. Interestingly, 3 µmol/L BAY K 8644 did not accelerate the effects of O2/glucose deprivation, but it significantly increased the peak amplitude and delayed the recovery time of both the membrane depolarization and of [Ca2+]i rise (Fig 5Down; 124±4%, P<.001, and 140±5.3%, P<.005, respectively, n=4).



View larger version (26K):
[in this window]
[in a new window]
 
Figure 5. Pharmacological modulation of the changes in [Ca2+]i and membrane depolarization induced by O2/glucose deprivation. Values are expressed in terms of percentage of the response to O2/glucose deprivation obtained with no pharmacological agents. Each bar represents the average of at least four experiments (±SEM). Nimodipine (20 µmol/L) significantly reduced both the rise in [Ca2+]i and membrane depolarization, whereas either TTX (1 µmol/L) or a combination of 50 µmol/L D-APV, plus 10 µmol/L CNQX, plus 500 µmol/L MCPG. Also dantrolene, 30 µmol/L, was unable to affect electrical and ionic alterations caused by O2/glucose deprivation. Note that application of BAY K 8644, 3 µmol/L, enhanced significantly the amplitude of depolarization and the increase in [Ca2+]i.

Effects of Blockade of Synaptic Transmission, Glutamate Receptor Activation and Intracellular Ca2+ Release
The blockade of synaptic transmission by 1 µmol/L TTX did not modify the alterations caused by O2/glucose depletion on cortical neurons. Fig 5Up shows that neither the electrical changes (96±5%, P<.001) nor the elevation in [Ca2+]i (97±5.2%, P<.005) were affected by TTX. To analyze the possible involvement of glutamate receptors in the induction of membrane potential changes and [Ca2+]i increase caused by in vitro ischemia, we preincubated the slices in a solution containing either ionotropic or metabotropic (group I and II) glutamate receptor antagonists. Fig 5Up shows that in the presence of 50 µmol/L D-APV, an antagonist of NMDA receptors, plus 10 µmol/L CNQX, an antagonist of AMPA receptors, plus 500 µmol/L MCPG, an antagonist of both group I and II metabotropic glutamate receptors, the membrane potential changes and [Ca2+]i rise induced by O2/glucose deprivation were unaffected (98.9±2.1, P<.001, and 98.6±1.9, P<.003, respectively, n=7). We finally addressed the possible role of intracellular Ca2+ stores by using dantrolene, a drug known to inhibit the intracellular release of Ca2+ by interfering with the Ca2+-induced Ca2+ release.21 Dantrolene (10–30 µmol/L) failed to significantly affect both membrane potential changes and [Ca2+]i rise induced by O2/glucose depletion (Fig 5Up, 96.9±2.1, P<.001 and 97.9±1.9, P<.005, n=6).


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
*Discussion
down arrowReferences
down arrowIntroduction 
down arrowReferences 
 
Four main findings emerge from our current study: (1) cortical pyramidal neurons respond to combined O2/glucose deprivation with an early hyperpolarization followed by a large, delayed depolarization of the cell membrane potential; (2) a simultaneous increase in [Ca2+]i occurs only in the latter phase of these electrical changes; (3) both the membrane potential changes and the elevation in [Ca2+]i could be strongly attenuated by L-type Ca2+ channel blockers, and enhanced by BAY K 8644, an agonist of L-type channels. (4) Conversely, glutamate receptor antagonists, TTX or dantrolene, failed to prevent the O2/glucose deprivation-induced electrical and ionic alterations. Taken together, these data suggest that during the early phases of ischemia a major part of the acute changes of both membrane potential and [Ca2+]i in cortical neurons is likely due to a net Ca2+ influx through voltage-gated L-type Ca2+ channels.

Both in vivo and in vitro experimental evidence supports the postulated role of increase in cytosolic Ca2+ in anoxic/ischemic brain damage.8 9 10 There is a partial agreement that most of [Ca2+]i increase derives from the extracellular space.22 23 24 25 Microfluorometric measurements of [Ca2+]i in cerebellar and hippocampal slices showed that large [Ca2+]i elevations induced in in vitro ischemia were mostly due to Ca2+ influx from the extracellular fluid.25 26 However, to date, the mode of entry of Ca2+ still represents a matter of debate. Several studies showed that the antagonism of both NMDA and non-NMDA glutamate receptors attenuates Ca2+ overload in the course of energy deprivation.23 27 28 However, the efficacy of glutamatergic antagonists in models of focal cerebral ischemia is still controversial.29 30 31 32 33 In our experimental condition, the contribution of either the ionotropic or metabotropic (group I and II) glutamate receptor to the membrane potential and [Ca2+]i changes appears negligible. It is noteworthy that, in most of the slice models of in vitro ischemia, glutamate receptors antagonism did not exert protective effects.34 35 In striatal and brain stem neurons, intracellularly recorded from slice preparations, the anoxia-induced membrane depolarization was not prevented by combined antagonism of NMDA and non-NMDA glutamate receptors.4 5 In a recent study, in fura 2–loaded cortical slices exposed to ischemia, the combined antagonism of NMDA and AMPA receptors slowed the rate of Ca2+ accumulation, but not the peak concentration of [Ca2+]i.36 In dissociated hippocampal neurons, Friedman and Haddad failed to prevent the anoxia-induced [Ca2+]i rise either by combined antagonism of NMDA and AMPA glutamate receptors or by TTX.35 Moreover, comparing the effects of glutamate- and anoxia-induced increase in [Ca2+]i, they found that neurons exhibited a completely different time-course in [Ca2+]i accumulation, suggesting that the mechanisms underlying these two events are dissimilar. These results were obtained from dissociated neurons, a preparation with no synaptic inputs. It is possible that some of the reasons for the discrepancy between the slice data and those obtained in cultures and "in vivo," can be attributed to the different experimental model used. Alternatively, it is possible that in our slice experiments we have evaluated only the "acute" effects of ischemia, whereas excitatory amino acids might play a major role in the "delayed neuronal death." Our data prove that even in a slice preparation, where synaptic inputs, neurotransmitter actions and glial functions are partially preserved, the blockade of either synaptic transmission or of glutamate receptors does not prevent the temporal profile of both membrane potential and [Ca2+]i changes caused by ischemia. The substantial attenuation of the modifications of both membrane potential and [Ca2+]i in the presence of nifedipine and nimodipine suggests that during O2/glucose depletion, the raise in [Ca2+]i is dependent, to a large extent, on Ca2+ entry through L-type Ca2+ channels. Moreover, the inability of dantrolene to prevent electrical and ionic changes induced by O2/glucose deprivation suggests that the release of Ca2+ from intracellular stores does not seem to play a major role in the early events of energy depletion. These findings appear to be in accordance with fluorescence imaging studies obtained from dissociated hippocampal CA1 neurons, in which, during anoxia, most of the Ca2+ influx occurs through cobalt-sensitive Ca2+ channels.35 In hippocampal slices, Lobner and Lipton found significant attenuation of 45Ca2+ uptake during the second 2.5 minutes of ischemia in the presence of nifedipine.22 Interestingly, it has been shown that cardiac arrest is associated with an elevation in the binding of a L-type Ca2+ channel specific ligand in cortical synaptosomes, suggesting that, during ischemia, the increase in the number of L-type channels in the cell membrane may allow an increased Ca2+ entry.37 Yet, in in vivo models of both focal and complete cerebral ischemia, dihydropyridines have been shown to ameliorate ischemic [Ca2+]i accumulation.38 39 40 However, a major problem in interpreting data from in vivo studies is identifying the site at which drugs act. In fact, these in vivo studies cannot distinguish between a relaxant effect on blood vessels, thus increasing blood flow, and an action at neuronal level.41 Our experimental model is represented by a slice preparation that lacks blood vessels. Therefore, the present results support a neuronal effect of L-type Ca2+ channel blockers.

Our experiments show that a minor portion of membrane potential changes (15±4.1%) and [Ca2+]i rise (16±3.9%) observed during O2/glucose omission was not blocked by dihydropyridine, suggesting the presence of an additional mechanism involved in the pathophysiological changes occurring in course of ischemia. We are currently investigating the possible mechanisms subtending these minor changes occurring in cortical cells in conditions of energy depletion.

Clinical Implications
Over the past years the involvement of intracellular Ca2+ in the ischemic cell death has become evident.8 9 This observation led to the hypothesis that the inhibition of Ca2+ influx might prove useful in the treatment of acute stroke. Various antagonists of voltage-dependent Ca2+ channels were investigated in a variety of stroke models with different degrees of efficacy.42 The overall results of several double-blind, randomized trials with nimodipine did not give the expected results. However, a recent meta-analysis of the nimodipine trials demonstrated that previous analyses had methodological flaws, the major of which was that patients were randomized up to 48 hours after stroke. In the meta-analysis it emerged that patients who had nimodipine within 12 hours after acute stroke had a beneficial outcome, supporting the idea that an early therapeutic intervention with L-type channel blockers might be useful.43 Another group of drugs recently developed, aimed at counteracting Ca2+ overload, was represented by glutamate receptor antagonists, in particular both competitive and noncompetitive NMDA antagonists. Unfortunately, most recently, clinical trials performed with a competitive NMDA antagonist were stopped, because it increased brain-related death rate.44

Our experimental model precludes the possibility to investigate the involvement of blood vessels. Indeed, thrombolytic agents are currently under evaluation in clinical trials; this approach seems to be effective in the clinical outcome of acute ischemic stroke.45 46 47 Understanding the pathophysiology of the different stages of ischemic stroke is of crucial importance to establish the exact criteria of the so-called therapeutic window and, consequently, for drug development.


*    Selected Abbreviations and Acronyms
 
AMPA = {alpha}-amino-3-hydroxy-5-methyl-4-isoxazole-propionate
CNQX = 6-cyano-7-nitroquinoxaline-2,3-dione
D-APV = D-2-amino-5-phosphonovalerate
EC50 = median effective concentration
MCPG = (S)-{alpha}-methyl-4-carboxyphenylglycine
TTX = tetrodotoxin


*    Acknowledgments
 
This work was partially supported by a M.U.R.S.T. grant (PNR/Neurobiologia-Tema 1) to G.B. We wish to thank Mr. M Tolu for his excellent technical assistance.

Received May 29, 1997; revision received September 4, 1997; accepted October 6, 1997.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
up arrowDiscussion
*References
down arrowIntroduction 
down arrowReferences 
 

  1. Martin RL, Lloyd HGE, Cowan AI. The early events of oxygen and glucose deprivation: setting the scene for neuronal death? Trends Neurosci. 1994;17:251–257.[Medline] [Order article via Infotrieve]
  2. Mercuri NB, Bonci A, Johnson SW, Stratta F, Calabresi P, Bernardi P. Effects of anoxia on rat midbrain dopamine neurons. J Neurophysiol. 1994;71:1165–1173.[Abstract/Free Full Text]
  3. Krnjevic K, Leblond J. Changes in membrane currents of hippocampal neurons evoked by brief anoxia. J Neurophysiol. 1989;62:15–30.[Abstract/Free Full Text]
  4. Haddad GG, Jiang C. Mechanisms of anoxia-induced depolarization in brainstem neurons: in vitro current and voltage clamp studies in the adult rat. Brain Res. 1993;625:261–263.[Medline] [Order article via Infotrieve]
  5. Calabresi P, Pisani A, Mercuri NB, Bernardi G. On the mechanisms underlying hypoxia-induced membrane depolarization in striatal neurons. Brain. 1995;118:1027–1038.[Abstract/Free Full Text]
  6. Jiang C, Haddad GG. Differential responses of neocortical neurons to glucose and/or O2 deprivation in the human and in the rat. J Neurophysiol. 1992;68:2165–2173.[Abstract/Free Full Text]
  7. Pisani A, Calabresi P, Bernardi G. Hypoxia in striatal and cortical neurons: membrane potential and Ca2+ measurements. Neuroreport. 1997;8:1143–1147.[Medline] [Order article via Infotrieve]
  8. Siesjo BK. Historical overview: calcium, ischemia and death of brain cells. Ann N Y Acad Sci. 1988;522:638–661.[Medline] [Order article via Infotrieve]
  9. Choi DW. Ionic dependence of glutamate neurotoxicity in cortical cell culture. J Neurosci. 1987;7:369–379.[Abstract]
  10. Silver IA, Erecinska M. Intracellular and extracellular changes of (Ca2+) in hypoxia and ischemia in rat brain in vivo. J Gen Physiol. 1990;95:837–866.[Abstract/Free Full Text]
  11. Lipton P. Regulation of glycogen in the dentate gyrus of the in vitro guinea pig hippocampus: effect of combined deprivation of glucose and oxygen. J Neurosci Methods. 1988;28:147–154.
  12. Lust WD, Arai H, Yasamoto Y, Whittingham TS, Djuricic B, Mrsulja BB, Passonneau JV. Ischemic encefalopathy. In: McCandless DM, ed. Cerebral Energy Metabolism and Metabolic Encefalopathy. New York, NY: Plenum; 1985:79–177.
  13. Calabresi P, Magarinos Ascone C, Centonze D, Pisani A, Sancesario G, D'Angelo V, Bernardi G. Opposite membrane potential changes induced by glucose deprivation in striatal spiny neurons and in large aspiny interneurons. J Neurosci. 1997;17:1940–1949.[Abstract/Free Full Text]
  14. Horikawa H, Armstrong WE. A versatile means of intracellular labeling: injection of biocytin and its detection with avidin conjugates. J Neurosci Methods. 1988;25:1–11.[Medline] [Order article via Infotrieve]
  15. Kawaguchi Y. Physiological, morphological and histochemical characterization of three classes of interneurons in the rat neostriatum. J Neurosci. 1993;13:4908–4923.[Abstract]
  16. Lev-Ram V, Miyakawa H, Lasser-Ross N, Ross WN. Calcium transients in cerebellar Purkinje neurons evoked by intracellular stimulation. J Neurophysiol. 1992;68:1167–1177.[Abstract/Free Full Text]
  17. Muri R, Knoepfel T. Activity induced elevations of intracellular calcium concentration in neurons of the deep cerebellar nuclei. J Neurophysiol. 1994;71:420–427.[Abstract/Free Full Text]
  18. Uematsu D, Greenberg JH, Reivich M, Karp A. In vivo measurement of cytosolic free calcium during cerebral ischemia and reperfusion. Ann Neurol. 1988;24:420–428.[Medline] [Order article via Infotrieve]
  19. McCormick DA, Connors BW, Lightall JW, Prince DA. Comparative electrophysiology of pyramidal and sparsely spiny stellate neurons of the neocortex. J Neurophysiol. 1985;54:782–806.[Abstract/Free Full Text]
  20. Connors BW, Gutnick MJ, Prince DA. Electrophysiological properties of neocortical neurons in vitro. J Neurophysiol. 1982;48:1302–1320.[Abstract/Free Full Text]
  21. Ward A, Chaffman MO, Sorkin EM. Dantrolene: a review of its pharmacological and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity. Drugs. 1986;32:130–168.[Medline] [Order article via Infotrieve]
  22. Lobner D, Lipton P. Intracellular calcium levels and calcium fluxes in the CA1 region of the rat hippocampal slice during in vitro ischemia: relationship to electrophysiological cell damage. J Neurosci. 1993;13:4861–4871.[Abstract]
  23. Goldberg MP, Choi DW. Combined oxygen and glucose deprivation in cortical cell culture: calcium-dependent and calcium-independent mechanisms of neuronal injury. J Neurosci. 1993;13:3510–3524.[Abstract]
  24. Dubinski JM, Rothman SM. Intracellular calcium concentration during "chemical hypoxia" and excitotoxic neuronal injury. J Neurosci. 1991;11:2545–2551.[Abstract]
  25. Mitani A, Yanase H, Sakai K, Wake Y, Kataoka K. Origin of intracellular Ca2+ elevation induced by in vitro ischemia-like condition in hippocampal slices. Brain Res. 1993;601:103–110.[Medline] [Order article via Infotrieve]
  26. Mitani A, Yanase H, Namba S, Shudo M, Kataoka K. In vitro ischemia-induced intracellular Ca2+ elevation in cerebellar slices: a comparative study with the values found in hippocampal slices. Acta Neuropathol. 1995;89:2–7.[Medline] [Order article via Infotrieve]
  27. Goldberg MP, Weiss JW, Pham PC, Choi DW. N-methyl-D-aspartate receptors mediate hypoxic neuronal injury in cortical culture. J Pharmacol Exp Ther. 1987;243:784–791.[Abstract/Free Full Text]
  28. Marcoux FW, Probert AW Jr, Weber ML. Hypoxic injury in cell culture: calcium accumulation blockade and neuroprotection by NMDA antagonists but not calcium-channel antagonists. In: Ginsberg MD, Dietrich WD, eds. Cerebrovascular Diseases. New York, NY: Raven Press; 1989:135–141.
  29. Block GA, Pulsinelli WA. N-methyl-D-aspartate receptor antagonists: failure to prevent ischemia-induced selective neuronal damage. In: Powers WJ, Raichle ME, eds. Cerebrovascular Diseases (15th Princeton Research Conferences on Cerebrovascular Diseases). New York, NY: Raven Press; 1987:23–34.
  30. Wieloch T, Gustafsson I, Westerberg E. Effects of the non-competitive NMDA receptor antagonist MK-801 on ischemic and hypoglycemic brain damage. In: Riss AR, ed. Frontiers in Excitatory Amino Acid Research. New York, NY: Raven Press; 1988:715–722.
  31. Katsuta K, Nakanishi H, Shirakawa K, Yoshida K, Takagi K, Tamura A. The neuroprotective effect of the novel noncompetitive NMDA antagonist, FR115427 in focal cerebral ischemia in rats. J Cereb Blood Flow Metab. 1995;15:345–348.[Medline] [Order article via Infotrieve]
  32. Nishikawa T, Kirsch JR, Koehler RC, Miyabe M, Traystman RJ. Competitive N-methyl-D-aspartate receptor blockade reduces brain injury following transient focal ischemia in cats. Stroke. 1994;25:2258–2264.[Abstract]
  33. Hossmann KA. Glutamate-mediated injury in focal cerebral ischemia: the excitotoxin hypothesis revised. Brain Pathol. 1994;4:23–26.[Medline] [Order article via Infotrieve]
  34. Haddad GG, Jiang C. O2 deprivation in the central nervous system: on mechanisms of neuronal response, differential sensitivity and injury. Prog Neurobiol. 1993;40:277–318.[Medline] [Order article via Infotrieve]
  35. Friedman JE, Haddad GG. Major differences in Ca2+i response to anoxia between neonatal and adult rat CA1 neurons: role of Ca2+o and Na+o. J Neurosci. 1993;13:63–72.[Abstract]
  36. Bickler PE, Hansen BM. Causes of calcium accumulation in rat cortical brain slices during hypoxia and ischemia: role of ion channels and membrane damage. Brain Res. 1994;665:269–276.[Medline] [Order article via Infotrieve]
  37. Hoehner PJ, Blanck TJJ, Roy R, Rosenthal RE, Fiskum G. Alteration of voltage-dependent calcium channels in canine brain during global ischemia and reperfusion. J Cereb Blood Flow Metab. 1992;12:418–424.[Medline] [Order article via Infotrieve]
  38. Abe K, Kogure K, Watanabe T. Prevention of ischemic and postischemic brain edema by a novel calcium antagonist (PN200–100). J Cereb Blood Flow Metab. 1988;8:436–439.[Medline] [Order article via Infotrieve]
  39. Steen PA, Gisvold SE, Milde JH. Nimodipine improves outcome when given after complete cerebral ischemia in primates. Anesthesiology. 1985;62:406–414.[Medline] [Order article via Infotrieve]
  40. Uematsu D, Greenberg JH, Hickey WF, Reivich M. Nimodipine attenuates both increases in cytosolic free calcium and histologic damage following focal cerebral ischemia and reperfusion in cats. Stroke. 1989;20:1531–1537.[Abstract/Free Full Text]
  41. Pringle AK, Benham CD, Sim L, Kennedy J, Iannotti F, Sundstrom LE. Selective N-type calcium channel antagonist omega conotoxin MVIIA is neuroprotective against hypoxic neurodegeneration in organotypic hippocampal-slice cultures. Stroke. 1996;27:2124–2130.[Abstract/Free Full Text]
  42. Grotta JC. Clinical aspects of the use of calcium channel antagonists in cerebrovascular disease. Clin Neuropharmacol. 1991;14:373–390.[Medline] [Order article via Infotrieve]
  43. Mohr JP, Orgogozo JM, Harrison MJG. Meta-analysis of nimodipine trials in acute ischemic stroke. Cerebrovasc Dis. 1994;14:373–390.
  44. Davis SM, Albers GW, Diener HC, Lees KR, Norris J. Termination of acute stroke studies involving selfotel treatment. ASSIST steering committed. Lancet. 1997;349:32.[Medline] [Order article via Infotrieve]
  45. Brott T. Thrombolysis for stroke. Arch Neurol. 1996;53:1305–1306.[Medline] [Order article via Infotrieve]
  46. Fisher M. Potentially effective therapies for acute ischemic stroke. Eur Neurol. 1995; 35:3–7.
  47. del Zoppo GJ. Thrombolysis in acute stroke. Neurologia. 1995;10(suppl 2):37–47.

Editorial Comment

Costantino Iadecola, MD, Guest Editor

Laboratory of Cerebrovascular Biology and Stroke, Department of Neurology, University of Minnesota, Minneapolis, Minnesota


*    Introduction 
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
up arrowDiscussion
up arrowReferences
*Introduction 
down arrowReferences 
 
A large body of evidence indicates that intracellular calcium accumulation is a critical step in the chain of events leading to ischemic neuronal death.1 2 However, the mechanisms of the increase in intracellular calcium and the calcium accumulation and anoxia-induced changes in membrane potentials have not been clearly defined. In the accompanying article, Pisani et al have used calcium-sensitive dyes and intracellular recordings in brain slices subjected to oxygen-glucose deprivation to provide additional insights into the mechanisms of calcium accumulation. By monitoring both intracellular calcium and membrane potential in morphlogically identified neurons, they were able to study the effect of pharmacological agents that block selected calcium entry pathways during oxygen-glucose deprivation. The results suggest that the majority of calcium enters neurons through voltage-gated L-type channels toward the late stage of membrane depolarization. Interestingly, the contribution of glutamate receptors and intracellular calcium pool was found to be negligible. The data reaffirm the importance of voltage-gated L-type calcium channels in the mechanisms of calcium influx in neurons after energy failure.

This elegant study uses state-of-the-art approaches to address a critical issue in the neurobiology of neuronal death secondary to energy deprivation. The results are of interest, as they provide new data in support of the importance of voltage-gated calcium channels in the mechanism of cerebral ischemia. In addition, the findings reemphasize that calcium channel blockers may be a viable therapeutic modality for the treatment of stroke. Of interest is the observation that in this preparation, glutamate receptor antagonists did not block calcium entry. This finding leads to the prediction that glutamate receptor antagonists are not effective in preventing the deleterious effects of intracellular calcium accumulation during energy failure. However, this conclusion is not supported by the abundant literature demonstrating a protective effect of glutamate receptor antagonists in focal cerebral ischemia and in neuronal cultures subjected to oxygen-glucose deprivation.3 4 While this discrepancy underscores the importance of the experimental model used when studying the consequences of cerebral ischemia, it also indicates that our understanding of the role of calcium and glutamate receptors in ischemic brain injury is far from complete. Future experiments focusing on the ionic changes elicited by activation of glutamate receptors would contribute to further elucidate the relation between glutamate and calcium influx in this model.


*    Selected Abbreviations and Acronyms
 
AMPA = {alpha}-amino-3-hydroxy-5-methyl-4-isoxazole-propionate
CNQX = 6-cyano-7-nitroquinoxaline-2,3-dione
D-APV = D-2-amino-5-phosphonovalerate
EC50 = median effective concentration
MCPG = (S)-{alpha}-methyl-4-carboxyphenylglycine
TTX = tetrodotoxin

Received May 29, 1997; revision received September 4, 1997; accepted October 6, 1997.


*    References 
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
up arrowDiscussion
up arrowReferences
up arrowIntroduction 
*References 
 

  1. Siesjö BK, Bengtsson F. Calcium fluxes, calcium antagonists, and calcium-related pathology in brain ischemia, hypoglycemia, and spreading depression: a unifying hypothesis. J Cereb Blood Flow Metab.. 1989;9:127-140.[Medline] [Order article via Infotrieve]
  2. Morley P, Hogan JH, Hakim AM. Calcium-mediated mechanisms of ischemic injury and protection. Brain Pathol.. 1994;4:37-47.[Medline] [Order article via Infotrieve]
  3. Hossmann K-A. Glutamate-mediated injury in focal cerebral ischemia: the excitotoxin hypothesis revised. Brain Pathol.. 1994;4:23-36.
  4. Choi DW. Glutamate receptors and the induction of excitotoxic neuronal death. Pro Brain Res.. 1994;100:47-51.



This article has been cited by other articles:


Home page
StrokeHome page
C. Costa, G. Martella, B. Picconi, C. Prosperetti, A. Pisani, M. Di Filippo, F. Pisani, G. Bernardi, and P. Calabresi
Multiple Mechanisms Underlying the Neuroprotective Effects of Antiepileptic Drugs Against In Vitro Ischemia
Stroke, May 1, 2006; 37(5): 1319 - 1326.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
I. Nikonenko, M. Bancila, A. Bloc, D. Muller, and P. Bijlenga
Inhibition of T-Type Calcium Channels Protects Neurons from Delayed Ischemia-Induced Damage
Mol. Pharmacol., July 1, 2005; 68(1): 84 - 89.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. F. Cano-Abad, M. Villarroya, A. G. Garcia, N. H. Gabilan, and M. G. Lopez
Calcium Entry through L-type Calcium Channels Causes Mitochondrial Disruption and Chromaffin Cell Death
J. Biol. Chem., October 19, 2001; 276(43): 39695 - 39704.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
P. Calabresi, G. A. Marfia, S. Amoroso, A. Pisani, G. Bernardi, and P. D. Hurn
Pharmacological Inhibition of the Na+/Ca2+ Exchanger Enhances Depolarizations Induced by Oxygen/Glucose Deprivation but Not Responses to Excitatory Amino Acids in Rat Striatal Neurons • Editorial Comment
Stroke, August 1, 1999; 30(8): 1687 - 1694.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
B. Infeld, S. M. Davis, G. A. Donnan, M. Yasaka, M. Lichtenstein, P. J. Mitchell, and G. J. Fitt
Nimodipine and Perfusion Changes After Stroke
Stroke, July 1, 1999; 30(7): 1417 - 1423.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
P. Calabresi, G. A. Marfia, D. Centonze, A. Pisani, G. Bernardi, and R. C. Koehler
Sodium Influx Plays a Major Role in the Membrane Depolarization Induced by Oxygen and Glucose Deprivation in Rat Striatal Spiny Neurons • Editorial Comment
Stroke, January 1, 1999; 30(1): 171 - 179.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pisani, A.
Right arrow Articles by Iadecola, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pisani, A.
Right arrow Articles by Iadecola, C.